Editor's Picks
Editor's Picks
BTIG Analyst Raises Price Target for Spyre Therapeutics (NASDAQ:SYRE) to $112 Amid Positive Clinical Trial Results
June 15, 2026
Editor's Picks
PDD Holdings Inc. (NASDAQ: PDD) Faces Headwinds: Underperform Rating, Legal Challenges, and Market Scrutiny
June 15, 2026Editor's Picks
CarMax, Inc. (NYSE: KMX) Q1 Earnings Preview: Key Financials and Market Outlook
June 15, 2026Anticipated Earnings Decline: Analysts project a significant year-over-year decrease in both earnings per share (EPS) and revenue for the upcoming quarter. Valuation Metrics: The company currently holds a trailing price-to-earnings...
Editor's Picks
We will not share your information & you can unsubscribe at any time. You agree to our terms of service & privacy policy. You agree to receive emails & correspondence from Nextmemealert.